(secondQuint)S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer.

 Purpose:evaluated the dose-limiting toxicity and recommended dose of S-1 for a future phase II study when administered concurrently with thoracic radiation in elderly patients (>70 years old) with esophageal Cancer.

 Methods:S-1 was administered on days 1-14 and 29-42 at the following dosages: 60, 70, and 80mg/m(2)/day.

 Thoracic radiation therapy was administered in 1.

8Gy fractions five times weekly to a total dose of 54 Gy.

.

 S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer@highlight

Elderly patients with esophageal cancer will receive thoracic radiation therapy 54Gy over 30 fractions, and concurrent with s-1 on days 1-14 and 29-42 at the following dosages: 60, 70, and 80 mg/m(2)/day.

